Results 121 to 130 of about 53,092 (237)

Non-alcoholic steatohepatitis incidence in patients with psoriasis vulgaris. [PDF]

Wien Med Wochenschr
Elhanon HM, Atallah RB, Eldahshan RM, Mohamed SED, Elsaie ML.   +4 more
europepmc   +1 more source

Non Alcoholic Steatohepatitis [PDF]

Advances in Cytology & Pathology, 2017
openaire   +1 more source

Loss of Posterior Occlusal Support Is Associated With Incident Steatotic Liver Disease in a Nationwide Longitudinal Analysis of the JMDC Claims Database

Hepatology Research, EarlyView.
ABSTRACT Aim Steatotic liver disease (SLD), including metabolic dysfunction–associated SLD (MASLD) and metabolic dysfunction–associated alcohol‐related liver disease (MetALD), is a growing global health burden. Although impaired mastication is linked to metabolic disorders, its role in SLD remains unclear.
Takashi Miyano, Taro Kusama, Manami Hoshi‐Harada, Ken Osaka, Kenji Takeuchi   +4 more
wiley   +1 more source

Hematological abnormalities in clinically diagnosed non-alcoholic steatohepatitis: prevalence, clinical correlates, and fibrosis risk in a case-control study from Qatar. [PDF]

Front Med (Lausanne)
Al-Khinji A, Malouche D, Al-Thani N, Mustafa A, Abdulmajeed J, Al-Kuwari MG.   +5 more
europepmc   +1 more source

Potential Role of Liver Transplantation for Child–Pugh Class A Hepatocellular Carcinoma: Prognosis and Medical Expenditure in Japan—A Retrospective Single‐Center Study

Hepatology Research, EarlyView.
Among patients with CP‐A HCC initially within the Japan criteria, some lose oncological eligibility for LT before hepatic decompensation. Further studies are needed to identify baseline factors associated with poor outcomes and to evaluate their relevance to future LT candidacy.
Akihiro Seki, Tomoyoshi Chiba, Shintaro Yagi, Rika Horii, Noboru Takata, Hiroki Nomura, Masaki Miyazawa, Tomoyuki Hayashi, Takeshi Terashima, Shinichi Nakanuma, Mitsuyoshi Okazaki, Satoshi Takada, Tatsuya Yamashita, Masao Honda, Hajime Takatori, Tetsuro Shimakami, Taro Yamashita   +16 more
wiley   +1 more source

Tofogliflozin attenuates liver steatosis and fibrosis in non-diabetic non-alcoholic steatohepatitis mice. [PDF]

BMC Gastroenterol
Ozono Y, Kawakami H, Hatada H, Uchiyama N, Ogawa S, Uchida K, Tamura H, Komaki Y, Nakamura K, Iwakiri H, Hasuike S, Nagata K.   +11 more
europepmc   +1 more source

A prospective study of 12‐month survival of patients with cirrhosis admitted to intensive care

Internal Medicine Journal, EarlyView.
Abstract Background The assessment on whether to escalate care in patients with cirrhosis to the intensive care unit (ICU) is complex, with little data on long‐term outcomes. The primary aim of this study was to prospectively examine the ability of liver‐specific and ICU prognostic scores to predict 12‐month survival among patients with cirrhosis in ...
Minnie Au, Xian J Mah, Sern W Yeoh, Anh D Pham, Ashley Bloom, Nina Parthasarathy, Stephen D Bloom, Rohit Sawhney, Peter Oziemski, Amanda J Nicoll   +9 more
wiley   +1 more source

F-53B exposure accelerates progression from preexisting fatty liver to non-alcoholic steatohepatitis and hepatic fibrosis. [PDF]

iScience
Hu C, Wu L, Zhang Z, Liu Y, Yang H, Zhou J, Wu Y, Wang Q.   +7 more
europepmc   +1 more source

The Oral‐Gut Axis: Bidirectional Interactions Between Microbiome and Diseases

Journal of Periodontal Research, EarlyView.
This study aims to summarize the mechanisms underlying ectopic colonization of the gut by oral pathobionts and the microbial and host factors that regulate this process. ABSTRACT Increased colonization of typically oral microorganisms is frequently observed in the gut mucosa or lumen of individuals with gastrointestinal disorders, including patients ...
Shinya Ebihara, Nobuhiko Kamada
wiley   +1 more source

<i>Agrimonia pilosa</i> Extract Alleviates CDAHFD-Induced Non-Alcoholic Steatohepatitis and Fibrosis in Mice. [PDF]

Nutrients
Jo MJ, Hwang SJ, Seo MG, Lee JH, Lee JW, Kim YH, Kim Y, Park SJ.   +7 more
europepmc   +1 more source